Publikationen von Tiago F. Outeiro
Alle Typen
Zeitschriftenartikel (132)
121.
Zeitschriftenartikel
40, S. 168 - 181 (2017)
Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Research Reviews 122.
Zeitschriftenartikel
4, 128 (2016)
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathologica Communications 123.
Zeitschriftenartikel
6, 36798 (2016)
Glycation potentiates neurodegeneration in models of Huntington's disease. Scientific Reports 124.
Zeitschriftenartikel
113 (42), S. E6506 - E6515 (2016)
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 125.
Zeitschriftenartikel
434, S. 238 - 249 (2016)
Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Molecular and Cellular Endocrinology 126.
Zeitschriftenartikel
6, 31493 (2016)
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports 127.
Zeitschriftenartikel
25 (14), S. 2959 - 2971 (2016)
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Human Molecular Genetics 128.
Zeitschriftenartikel
12 (6), e1006098 (2016)
C-terminal tyrosine residue modifications modulate the protective phosphorylation of Serine 129 of α-synuclein in a yeast model of Parkinson's disease. PLoS Genetics 129.
Zeitschriftenartikel
31 (6), S. 782 - 790 (2016)
Glycation in Parkinson's disease and Alzheimer's disease. Movement Disorders 130.
Zeitschriftenartikel
12, e1005995 (2016)
shRNA-based screen identifiers endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity. PLoS Genetics 131.
Zeitschriftenartikel
25 (2), S. 275 - 290 (2016)
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Human Molecular Genetics 132.
Zeitschriftenartikel
6, e1994 (2015)
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death and Disease Buchkapitel (3)
133.
Buchkapitel
Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia. In: Handbook of Neurotoxicity, S. 1539 - 1559 (Hg. Kostrzewa, R. M.). Springer, Cham (2022)
134.
Buchkapitel
Sirtuins in brain and neurodegenerative disease. In: Introductory review on sirtuins in biology, aging, and aging disease, S. 175 - 195 (Hg. Guarente, L.) (2018)
135.
Buchkapitel
Epigenetics in Parkinson's disease. In: Neuroepigenomics in aging and disease (Hg. Delgado Morales, R.) (2017)
Editorial (4)
136.
Editorial
168 (8), S. 1421 - 1683 (2024)
Aging and neurodegeneration: From molecular mechanisms to therapeutic interventions. Journal of Neurochemistry 137.
Editorial
15, 1399709 (2024)
One health care in psychiatric and neurological diseases. Frontiers in Psychiatry 138.
Editorial
17, 1216902 (2023)
Editorial: Personalized care in neurological diseases. Frontiers in Human Neuroscience 139.
Editorial
10 (3), S. 295 - 296 (2018)
SIRT2 in age-related neurodegenerative disorders. Aging Preprint (1)
140.
Preprint
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features. medRxiv (2025)